Treatment of Endometriosis with the GnRHa Deslorelin and Add-Back Estradiol and Supplementary Testosterone

Background. This randomized, multicenter, open-label clinical trial was intended to generate pilot data on the efficacy and safety of the gonadotropin-releasing hormone agonist (GnRHa) deslorelin (D) with low-dose estradiol ± testosterone (E(2)  ± T) add-back for endometriosis-related pelvic pain. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarwal, Sanjay K., Daniels, AnnaMarie, Drosman, Steven R., Udoff, Laurence, Foster, Warren G., Pike, Malcolm C., Spicer, Darcy V., Daniels, John R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736002/
https://www.ncbi.nlm.nih.gov/pubmed/26881208
http://dx.doi.org/10.1155/2015/934164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736002/
https://www.ncbi.nlm.nih.gov/pubmed/26881208
http://dx.doi.org/10.1155/2015/934164

Ejemplares similares